A brief guide to machine learning for antibiotic discovery br

被引:14
作者
Liu, Gary [1 ,2 ,3 ]
Stokes, Jonathan M. [1 ,2 ,3 ]
机构
[1] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada
[2] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada
[3] McMaster Univ, David Braley Ctr Antibiot Discovery, Hamilton, ON, Canada
关键词
DRUG DISCOVERY; CHEMISTRY;
D O I
10.1016/j.mib.2022.102190
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Rising antibiotic resistance and an alarmingly lean antibiotic pipeline require the adoption of novel approaches to rapidly discover new structural and functional classes of antibiotics. Excitingly, algorithmic approaches to antibiotic discovery are sufficiently advanced to meaningfully influence the antibiotic discovery process. Indeed, once trained on high-quality datasets, contemporary machine-learning and deep-learning models can be used to perform predictions for new antibiotics across vast chemical spaces, orders of magnitude more rapidly than compounds can be screened in the laboratory. This increases the probability of discovering new antibiotics with desirable properties. In this short review, we briefly describe the utility of contemporary machine-learning and deep-learning approaches to guide the discovery of new small-molecule antibiotics and unidentified natural products. We then propose a call to action for more open sharing of high-quality screening datasets to accelerate the rate at which forthcoming antibioticprediction models can be trained. Together, we aim to introduce antibiotic discoverers to a sample of recent applications of contemporary algorithmic methods to facilitate the wider adoption of these powerful computational approaches.
引用
收藏
页数:6
相关论文
共 47 条
[11]   CORRELATION OF BIOLOGICAL ACTIVITY OF PHENOXYACETIC ACIDS WITH HAMMETT SUBSTITUENT CONSTANTS AND PARTITION COEFFICIENTS [J].
HANSCH, C ;
MALONEY, PP ;
FUJITA, T .
NATURE, 1962, 194 (4824) :178-&
[12]   Support vector machines for drug discovery [J].
Heikamp, Kathrin ;
Bajorath, Juergen .
EXPERT OPINION ON DRUG DISCOVERY, 2014, 9 (01) :93-104
[13]   Principles of early drug discovery [J].
Hughes, J. P. ;
Rees, S. ;
Kalindjian, S. B. ;
Philpott, K. L. .
BRITISH JOURNAL OF PHARMACOLOGY, 2011, 162 (06) :1239-1249
[14]   Expansion of RiPP biosynthetic space through integration of pan-genomics and machine learning uncovers a novel class of lantibiotics [J].
Kloosterman, Alexander M. ;
Cimermancic, Peter ;
Elsayed, Somayah S. ;
Du, Chao ;
Hadjithomas, Michalis ;
Donia, Mohamed S. ;
Fischbach, Michael A. ;
van Wezel, Gilles P. ;
Medema, Marnix H. .
PLOS BIOLOGY, 2020, 18 (12)
[15]   Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria [J].
Kortright, Kaitlyn E. ;
Chan, Benjamin K. ;
Koff, Jonathan L. ;
Turner, Paul E. .
CELL HOST & MICROBE, 2019, 25 (02) :219-232
[16]   Straightforward recursive partitioning model for discarding insoluble compounds in the drug discovery process [J].
Lamanna, Claudia ;
Bellini, Marta ;
Padova, Alessandro ;
Westerberg, Goran ;
Maccari, Laura .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (10) :2891-2897
[17]  
Landrum G, RDKit: a software suite for cheminformatics, computational chemistry, and predictive modeling
[18]  
Lei J, 2019, AM J TRANSL RES, V11, P3919
[19]   Recover the lost art of drug discovery [J].
Lewis, Kim .
NATURE, 2012, 485 (7399) :439-440
[20]   Support vector machines and its applications in chemistry [J].
Li, Hongdong ;
Liang, Yizeng ;
Xu, Qingsong .
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 2009, 95 (02) :188-198